Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and efficacy of preoperative
intravenous ferric carboxymaltose in patients with anemia undergoing hip or knee replacement